BCM
CELU icon

Beryl Capital Management’s Celularity CELU Stock Holding History

Beryl Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,461
Closed -$352K – 224
2021
Q2 		$352K Buy
+3,461
New +$351K 0.03% 181
2021
Q1 		– Sell
-18,894
Closed -$2.08M – 211
2020
Q4 		$2.08M Buy
+18,894
New +$2.01M 0.33% 119

Other funds holding CELU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Beryl Capital Management's CELU Position: Q3 2021 in Review

Beryl Capital Management sold out of Celularity (CELU) in Q3 2021, closing a stake of 3,461 shares — an estimated $352K sold.

Beryl Capital Management first reported a position in CELU in Q4 2020 and held it in 2 quarters. The position peaked at $2.08M in Q4 2020. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

  • Beryl Capital Management reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
  • Beryl Capital Management sold 3,461 Celularity shares in Q3 2021, an estimated $352K.
  • Beryl Capital Management first reported a position in Celularity in Q4 2020 and held it in 2 quarters.
  • Beryl Capital Management's Celularity position peaked at $2.08M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Beryl Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.